The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Vertex Pharmaceuticals Inc

Nasdaq: VRTX
Last

(U.S.) $151.73

Today's change+0.36 +0.24%
Updated August 17 9:38 AM EDT. Delayed by at least 15 minutes.
 

Vertex Pharmaceuticals Inc

Nasdaq: VRTX
Last

(U.S.) $151.73

Today's change+0.36 +0.24%
Updated August 17 9:38 AM EDT. Delayed by at least 15 minutes.

Vertex Pharmaceuticals Inc up (U.S.)$0.36

Vertex Pharmaceuticals Inc is up today by (U.S.)$0.36 or 0.24% to (U.S.)$151.73. Over the last five days, shares have gained 2.15% and 105.96% year to date. Shares have outperformed the S&P 500 by 39.05% during the last year.

Key company metrics

  • Open(U.S.) $150.93
  • Previous close(U.S.) $151.37
  • High(U.S.) $151.73
  • Low(U.S.) $150.93
  • Bid / Ask(U.S.) $151.51 / (U.S.) $151.73
  • YTD % change+105.96%
  • Volume18,548
  • Average volume (10-day)1,065,743
  • Average volume (1-month)2,278,556
  • Average volume (3-month)1,945,910
  • 52-week range(U.S.) $71.46 to (U.S.) $167.86
  • Beta1.77
  • Trailing P/E146.86×
  • P/E 1 year forward95.92×
  • Forward PEG1.41×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.03
Updated August 17 9:38 AM EDT. Delayed by at least 15 minutes.

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue544715459414
Total other revenue--------
Total revenue544715459414
Gross profit474668399361
Total cost of revenue71466053
Total operating expense491444419433
Selling / general / administrative127113110106
Research & development289274248272
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)41000
Other operating expenses, total1111
Operating income5327140-19
Interest income (expense), net non-operating-15-17----
Gain (loss) on sale of assets--------
Other--------
Income before tax3625420-39
Income after tax3125028-40
Income tax, total44-71
Net income1824833-39
Total adjustments to net income00----
Net income before extra. items1824833-39
Minority interest-13-251
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1824733-39
Inc. avail. to common incl. extra. items1824733-39
Diluted net income1824733-39
Dilution adjustment--------
Diluted weighted average shares252251245245
Diluted EPS excluding extraordinary itemsvalue per share0.070.990.13-0.16
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.081.030.13-0.16